Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation
出版年份 2018 全文链接
标题
Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation
作者
关键词
Breast cancer, Trastuzumab-emtansine, T-DM1, HER2, Exosome
出版物
BMC CANCER
Volume 18, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-05-02
DOI
10.1186/s12885-018-4418-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- KeepEX, a simple dilution protocol for improving extracellular vesicle yields from urine
- (2017) M. Puhka et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Extracellular vesicle isolation and characterization: toward clinical application
- (2016) Rong Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- The biology and function of exosomes in cancer
- (2016) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- Versatile roles of extracellular vesicles in cancer
- (2016) Nobuyoshi Kosaka et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes
- (2015) Ikuhiko Nakase et al. Scientific Reports
- Trastuzumab emtansine: mechanisms of action and drug resistance
- (2014) Mark Barok et al. BREAST CANCER RESEARCH
- Biogenesis and secretion of exosomes
- (2014) Joanna Kowal et al. CURRENT OPINION IN CELL BIOLOGY
- Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
- (2013) Sara A. Hurvitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
- (2013) Michael Ritchie et al. mAbs
- Exosome-mediated delivery of siRNA in vitro and in vivo
- (2012) Samir El-Andaloussi et al. Nature Protocols
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer
- (2011) Mark Barok et al. CANCER LETTERS
- Microvesicles: Messengers and mediators of tumor progression
- (2011) Khalid Al-Nedawi et al. CELL CYCLE
- Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy
- (2011) Valentina Ciravolo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
- (2010) Teemu T. Junttila et al. BREAST CANCER RESEARCH AND TREATMENT
- Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes
- (2009) Josiah Ochieng et al. EXPERIMENTAL CELL RESEARCH
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More